| 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative F Van Den Hoogen, D Khanna, J Fransen, SR Johnson, M Baron, ... Arthritis & Rheumatism 65 (11), 2737-2747, 2013 | 5667 | 2013 |
| Infliximab and methotrexate in the treatment of rheumatoid arthritis PE Lipsky, DMFM van der Heijde, EW St. Clair, DE Furst, FC Breedveld, ... New England Journal of Medicine 343 (22), 1594-1602, 2000 | 4086 | 2000 |
| 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis JA Singh, KG Saag, SL Bridges Jr, EA Akl, RR Bannuru, MC Sullivan, ... Arthritis & rheumatology 68 (1), 1-26, 2016 | 3881 | 2016 |
| American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis DT Felson, JJ Anderson, M Boers, C Bombardier, D Furst, C Goldsmith, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1995 | 3425 | 1995 |
| Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase … R Maini, EW St Clair, F Breedveld, D Furst, J Kalden, M Weisman, ... The Lancet 354 (9194), 1932-1939, 1999 | 3147 | 1999 |
| Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial ME Weinblatt, EC Keystone, DE Furst, LW Moreland, MH Weisman, ... Arthritis & Rheumatism 48 (1), 35-45, 2003 | 2473 | 2003 |
| 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid … JA Singh, DE Furst, A Bharat, JR Curtis, AF Kavanaugh, JM Kremer, ... Arthritis care & research 64 (5), 625-639, 2012 | 2279 | 2012 |
| Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis DO Clegg, DJ Reda, CL Harris, MA Klein, JR O'Dell, MM Hooper, ... New England Journal of Medicine 354 (8), 795-808, 2006 | 2180 | 2006 |
| The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials DT Felson, JJ Anderson, M Boers, C Bombardier, M Chernoff, B Fried, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1993 | 2156 | 1993 |
| American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease‐modifying antirheumatic drugs in rheumatoid arthritis KG Saag, GG Teng, NM Patkar, J Anuntiyo, C Finney, JR Curtis, ... Arthritis Care & Research: Official Journal of the American College of …, 2008 | 2057 | 2008 |
| 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia D Khanna, JD Fitzgerald, PP Khanna, S Bae, MK Singh, T Neogi, ... Arthritis care & research 64 (10), 1431-1446, 2012 | 2016 | 2012 |
| Cyclophosphamide versus placebo in scleroderma lung disease DP Tashkin, R Elashoff, PJ Clements, J Goldin, MD Roth, DE Furst, ... New England Journal of Medicine 354 (25), 2655-2666, 2006 | 2009 | 2006 |
| Etanercept therapy in rheumatoid arthritis: a randomized, controlled trial LW Moreland, MH Schiff, SW Baumgartner, EA Tindall, RM Fleischmann, ... Annals of internal medicine 130 (6), 478-486, 1999 | 1965 | 1999 |
| American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials DT Felson, JS Smolen, G Wells, B Zhang, LHD Van Tuyl, J Funovits, ... Annals of the rheumatic diseases 70 (3), 404-413, 2011 | 1959 | 2011 |
| Update of EULAR recommendations for the treatment of systemic sclerosis O Kowal-Bielecka, J Fransen, J Avouac, M Becker, A Kulak, Y Allanore, ... Annals of the rheumatic diseases 76 (8), 1327-1339, 2017 | 1240 | 2017 |
| Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial DP Tashkin, MD Roth, PJ Clements, DE Furst, D Khanna, EC Kleerup, ... The lancet Respiratory medicine 4 (9), 708-719, 2016 | 1075 | 2016 |
| 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis D Khanna, PP Khanna, JD Fitzgerald, MK Singh, S Bae, T Neogi, ... Arthritis care & research 64 (10), 1447-1461, 2012 | 998 | 2012 |
| American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis JM Grossman, R Gordon, VK Ranganath, C Deal, L Caplan, W Chen, ... Arthritis care & research 62 (11), 1515-1526, 2010 | 979 | 2010 |
| Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist JH Korn, M Mayes, M Matucci Cerinic, M Rainisio, J Pope, E Hachulla, ... Arthritis & Rheumatism 50 (12), 3985-3993, 2004 | 933 | 2004 |
| Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis … CE Antoni, A Kavanaugh, B Kirkham, Z Tutuncu, GR Burmester, ... Arthritis & Rheumatism 52 (4), 1227-1236, 2005 | 848 | 2005 |
